Get started
Award

NCT03940235

Funded outputs count: 5
Funder award ID: NCT03940235
OpenAlex ID: G1660142298
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025 · Giulia Marvaso, Giulia Corrao, et al. · The Lancet Oncology · 105
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers
2023 · Luca Bergamaschi, Maria Giulia Vincini, et al. · Supportive Care in Cancer · 26
PDF
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer
2022 · Francesco La Fauci, Matteo Augugliaro, et al. · Applied Sciences · 3
PDF
Intensity-Modulated Radiotherapy (IMRT) following Conservative Surgery of the Supraglottic Region: Impact on Functional Outcomes
2022 · Daniela Alterio, Simona Marani, et al. · Cancers · 2
PDF
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches
2021 · Giulia Marvaso, Giulia Corrao, et al. · Frontiers in Oncology · 6
PDF